Présentation de l'entreprise
Translational Development Acquisition Corp. (TDAC) operates as a shell company within the Financial Services sector, specifically classified under the industry of Shell Companies, with no significant current operations beyond its intention to complete a business combination. As a special purpose acquisition company (SPAC), the entity is structured to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses, rather than generating revenue through traditional product sales or services. The company currently holds a market capitalization of $232.22M, while specific annual revenue figures and employee counts are not reported in the available data. This valuation indicates that the market is pricing the stock based on potential future merger targets and SPAC dynamics rather than current operational cash flows, reflecting a speculative position common for shell companies awaiting a definitive business combination.
Santé financière
The company reports a net income of $6.36M over the trailing twelve months, while revenue and EBITDA figures are not available due to the nature of its current non-operational status. The gap between the reported net income and the absence of revenue highlights a cost structure where income is likely derived from non-operating activities, such as interest income or unrealized gains, rather than core business profitability. Free cash flow stands at $-254,185, indicating a negative cash position that suggests the company is consuming cash reserves to maintain operations or fund search costs for a target. Total cash on hand is limited to $29,787, which is significantly outweighed by total debt of $200,000, creating a precarious liquidity profile for a financial services entity. All three margin metrics—Gross Margin, Operating Margin, and Profit Margin—are reported at 0.0%, confirming that the entity generates no gross profit or operating profit from its current activities. The balance sheet appears leveraged with a debt-to-equity ratio listed as N/A, yet the current ratio of 0.07 reveals severe short-term liquidity constraints, as current liabilities vastly exceed current assets. Return on Equity and Return on Assets are not applicable or negative, with ROA specifically recorded at -0.3%, which indicates that the management is not generating positive returns on the assets currently deployed.
Évaluation de la valorisation
The trailing twelve-month P/E ratio is 36.55, whereas the forward P/E is not available, implying that future earnings expectations are currently undefined until a merger transaction closes. The price-to-book ratio is -7.54, a negative figure that indicates the market cap exceeds the book value in a way typical for SPACs with negative equity or specific accounting treatments, rather than suggesting a market premium over tangible assets. Since price-to-sales and EV/EBITDA metrics are not available (N/A), these alternative valuation methods cannot be utilized to assess the company's intrinsic value relative to its sales or operational efficiency. The stock's 52-week high is $10.60 and the 52-week low is $10.08, placing the current trading price within a very narrow range near the upper bound of its annual volatility. The beta value is not available, which prevents a direct comparison of the stock's price volatility relative to the broader market index based on historical correlation data.
Growth & Income
Revenue growth and earnings growth year-over-year are not available (N/A) because the company has not yet established a recurring revenue stream or earnings history prior to its business combination. Consequently, the comparison between earnings growth and revenue growth rates is not applicable, as the entity has not demonstrated a trajectory of organic expansion or contraction in its financial performance. The company does not pay dividends, as evidenced by a dividend yield of N/A and a payout ratio of 0.0%, meaning the entity reinvests all available capital and earnings into the pursuit of a merger target rather than distributing income to shareholders. This non-dividend profile aligns with the strategic objective of SPACs to preserve capital for the acquisition of a profitable operating business. The overall growth and income profile of Translational Development Acquisition Corp. is currently characterized by a lack of historical growth data and a complete absence of dividend income, relying entirely on the successful execution of its planned business combination to generate future value.